{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:50:06Z","timestamp":1790437806596,"version":"4.1.0"},"reference-count":27,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Thrombomodulin functions as an anticoagulant through thrombin binding and protein C activation. We herein report the first case of hereditary functional thrombomodulin deficiency presenting with recurrent subcutaneous hemorrhage and old cerebral infarction. The patient had a homozygous substitution of glycine by aspartate at amino acid residue 412 (Gly412Asp) in the thrombin-binding domain of the thrombomodulin gene (designated thrombomodulin-Nagasaki). In vitro assays using a recombinant thrombomodulin with the same mutation as the patient showed a total lack of thrombin binding and activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI). Marked clinical and laboratory improvement was obtained with recombinant human soluble thrombomodulin therapy.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001155","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T11:40:08Z","timestamp":1592394008000},"page":"2631-2639","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation"],"prefix":"10.1182","volume":"4","author":[{"given":"Masahiko","family":"Okada","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nagasaki University Hospital, Nagasaki, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Tominaga","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nagasaki University Hospital, Nagasaki, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goichi","family":"Honda","sequence":"first","affiliation":[{"name":"Department of Medical Affairs, Asahi Kasei Pharma Corporation, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Nishioka","sequence":"first","affiliation":[{"name":"Department of Clinical Nutrition, Faculty of Health Science, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Akita","sequence":"first","affiliation":[{"name":"Department of Clinical Engineering, Faculty of Medical Engineering, Suzuka University of Medical Science, Suzuka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Mie Prefectural College of Nursing, Tsu, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Molecular Pathobiology, Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Moriuchi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nagasaki University Hospital, Nagasaki, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"issue":"2","key":"2020061711392206400_B1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0021-9258(19)68276-1","article-title":"Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C","volume":"257","author":"Esmon","year":"1982","journal-title":"J Biol Chem"},{"issue":"7","key":"2020061711392206400_B2","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/j.1460-2075.1987.tb02448.x","article-title":"Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation","volume":"6","author":"Suzuki","year":"1987","journal-title":"EMBO J"},{"key":"2020061711392206400_B3","first-page":"614545","article-title":"Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis","volume":"2012","author":"Okamoto","year":"2012","journal-title":"Crit Care Res Pract"},{"issue":"3","key":"2020061711392206400_B4","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0021-9258(18)33076-X","article-title":"Inactivation of human coagulation factor V by activated protein C","volume":"258","author":"Suzuki","year":"1983","journal-title":"J Biol Chem"},{"issue":"28","key":"2020061711392206400_B5","doi-asserted-by":"crossref","first-page":"16603","DOI":"10.1074\/jbc.271.28.16603","article-title":"TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex","volume":"271","author":"Bajzar","year":"1996","journal-title":"J Biol Chem"},{"issue":"9","key":"2020061711392206400_B6","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/S0021-9258(18)83672-9","article-title":"A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation","volume":"264","author":"Suzuki","year":"1989","journal-title":"J Biol Chem"},{"issue":"1","key":"2020061711392206400_B7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2020061711392206400_B8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.thromres.2013.03.008","article-title":"Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation","volume":"131","author":"Mimuro","year":"2013","journal-title":"Thromb Res"},{"issue":"9","key":"2020061711392206400_B9","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med"},{"issue":"4","key":"2020061711392206400_B10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/01.ATV.0000208365.45200.41","article-title":"Thrombomodulin gene polymorphisms and haplotypes and the risk of cardiovascular events: a prospective follow-up study","volume":"26","author":"Auro","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2020061711392206400_B11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"2020061711392206400_B12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1073\/pnas.92.3.850","article-title":"Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system","volume":"92","author":"Healy","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2020061711392206400_B13","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1172\/JCI2006","article-title":"A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state","volume":"101","author":"Weiler-Guettler","year":"1998","journal-title":"J Clin Invest"},{"issue":"5","key":"2020061711392206400_B14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/oxfordjournals.jbchem.a123295","article-title":"Monoclonal antibodies for human thrombomodulin which recognize binding sites for thrombin and protein C","volume":"108","author":"Hayashi","year":"1990","journal-title":"J Biochem"},{"issue":"3","key":"2020061711392206400_B15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0009-8981(90)90221-D","article-title":"One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies","volume":"192","author":"Kodama","year":"1990","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2020061711392206400_B16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood.V85.2.330.330","article-title":"The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease","volume":"85","author":"Ohlin","year":"1995","journal-title":"Blood"},{"issue":"1","key":"2020061711392206400_B17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/bmt.2016.195","article-title":"The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model","volume":"52","author":"Ikezoe","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2020061711392206400_B18","first-page":"553","article-title":"Thrombin generation, a function test of the haemostatic-thrombotic system","volume":"96","author":"Hemker","year":"2006","journal-title":"Thromb Haemost"},{"key":"2020061711392206400_B19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.thromres.2016.09.011","article-title":"Anti-inflammatory and anti-fibrinolytic effects of thrombomodulin alfa through carboxypeptidase B2 in the presence of thrombin","volume":"147","author":"Tawara","year":"2016","journal-title":"Thromb Res"},{"issue":"33","key":"2020061711392206400_B20","doi-asserted-by":"crossref","first-page":"20156","DOI":"10.1016\/S0021-9258(17)30483-0","article-title":"Further localization of binding sites for thrombin and protein C in human thrombomodulin","volume":"265","author":"Hayashi","year":"1990","journal-title":"J Biol Chem"},{"issue":"1","key":"2020061711392206400_B21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/biol.2001.0318","article-title":"Establishment of a standard assay method for human thrombomodulin and determination of the activity of the Japanese reference standard","volume":"30","author":"Niimi","year":"2002","journal-title":"Biologicals"},{"issue":"18","key":"2020061711392206400_B22","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1016\/S0021-9258(18)81626-X","article-title":"The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity","volume":"264","author":"Zushi","year":"1989","journal-title":"J Biol Chem"},{"issue":"20","key":"2020061711392206400_B23","doi-asserted-by":"crossref","first-page":"12135","DOI":"10.1074\/jbc.273.20.12135","article-title":"Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C","volume":"273","author":"Kokame","year":"1998","journal-title":"J Biol Chem"},{"issue":"16","key":"2020061711392206400_B24","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1016\/S0021-9258(19)49869-4","article-title":"The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity","volume":"267","author":"Ye","year":"1992","journal-title":"J Biol Chem"},{"issue":"6777","key":"2020061711392206400_B25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/35006683","article-title":"Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex","volume":"404","author":"Fuentes-Prior","year":"2000","journal-title":"Nature"},{"issue":"2","key":"2020061711392206400_B26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1432-1327.1999.00398.x","article-title":"The interaction of thrombomodulin with Ca2+","volume":"262","author":"Light","year":"1999","journal-title":"Eur J Biochem"},{"issue":"4","key":"2020061711392206400_B27","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/S0021-9258(18)53856-4","article-title":"Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity","volume":"268","author":"Nagashima","year":"1993","journal-title":"J Biol Chem"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2631\/1745104\/advancesadv2019001155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/12\/2631\/1745104\/advancesadv2019001155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T14:43:37Z","timestamp":1616251417000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/12\/2631\/460969\/A-case-of-thrombomodulin-mutation-causing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001155","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738189123.793577421","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]}}}